ASM Microbe 2018

ASM Microbe 2018

Thirteen AWG member companies presented data from their clinical and research programs at the American Society for Microbiology’s ASM Microbe 2018 meeting held June 7-11, 2018 in Atlanta, GA. Representatives from AWG member companies participated in 88 different presentations and oral sessions.

ASM Microbe showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application.

 

Friday, June 8th

 

Session 012: New Agents Discovery Summary Session: Early New Antimicrobial Agents
Time: 8:45 a.m. – 10:45 a.m. ET
Location: A411 and Lounge and Learn 1, Building A, Level 4

Amplyx:
9:30 a.m. – 9:45 a.m.

Session 040: FRIDAY – CPHM Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 042: CPHM02 – Antimicrobial Susceptibility Testing: Gram-Negative Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 048: FRIDAY – AAR Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Cidara Therapeutics:

Melinta Therapeutics:

Session 049: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Antimicrobial Surveillance Studies in HospitalsTime: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Theravance Biopharma:

Session 050: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Molecular Typing and Evolution of Resistance in Staphylococci, Enterococci and Streptococci
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 054: AAR03 – Antifungal Agents and Resistance: Agents to Treat Fungal Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Amplyx:

Cidara Therapeutics:

SCYNEXIS:

Session 056: AAR04 – Antimicrobial PK/PD & General Pharmacology: In vitro Models
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Zavante Therapeutics:

Session 061 – AAR07 – Experimental Therapeutics: New Targets, Scaffolds, Combinations and Delivery Systems
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 067: CIV01 – Clinical Studies of Adult Infectious Diseases: Skin, Bone and Joint Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 068: CIV01 – Clinical Studies of Adult Infectious Diseases: Urogenital Tract Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Iterum Therapeutics:

Session 150: PK/PD Optimized Antimicrobial Therapy
Time: 3:00 p.m. – 3:45 p.m. ET
Location: Lounge and Learn 2, Building A, Level 3

Spero Therapeutics:
3:10 p.m. – 3:15 p.m.

3:25 p.m. – 3:30 p.m.

 

 

Saturday, June 9th

 

Session 205: Resistant Gram-negative Pathogens in the Hospital
Time: 11:00 a.m. – 12:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5, CIV Hub, Learn

Melinta Therapeutics:
11:40 a.m. – 11:50 a.m. ET

Session 218: SATURDAY – CPHM Late-breakers
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 219: CPHM02 – Antimicrobial Susceptibility Testing: Gram-positive and Fastidious Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Theravance Biopharma:

Session 220: CPHM03 – Diagnostic Bacteriology: Consider the Source
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

T2 Biosystems:

Session 227: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Community-associated Infections by Multidrug-Resistant Bacteria
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Session 233: AAR04 – Antimicrobial PK/PD & General Pharmacology: in vivo Studies
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Melinta Therapeutics:

Spero Therapeutics:

Session 234: AAR05 – Antimicrobial Stewardship, including Quality of Care: Global Stewardship
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Nabriva Therapeutics:

Session 235: AAR08 – New Antimicrobial Agents and New Research Technologies: Peptide and Glycopeptide Antimicrobial Agents
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Spero Therapeutics:

Session 236: AAR09 – Pharmacological Studies of Antimicrobial Agents Pre-NDA (Phase 2/3): New Agents between Phase 2 and FDA Approval
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Motif Bio:

Nabriva Therapeutics:

Paratek Pharmaceuticals:

Zavante Therapeutics:

 

Session 239: 239 – CIV01 – Clinical Studies of Adult Infectious Diseases: Staphylococcal and Other Gram-positive Infections
Time: 11:00 a.m. – 1:00 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Paratek Pharmaceuticals:

Session 313: New Antibacterial Drugs, New Inhibitors: What, When, How
Time: 1:30 p.m. – 4:00 p.m.
Location: A410

Melinta Therapeutics:
3:00 p.m. – 3:30p p.m.

 

Sunday, June 10th

 

Session 384: SUNDAY – HMB Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 394: SUNDAY – CPHM Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

T2 Biosystems:

Session 403: SUNDAY – AAR Late-breakers
Time: 12:45 p.m. – 2:45 p.m. ET

Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 404: AAR01 – Surveillance of AMR: Molecular Typing, Clinical & Molecular Epidemiology: Global Surveillance Studies
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 410: AAR08 – New Antimicrobial Agents and New Research Technologies: Bacteriophage-Related Tools and Therapy
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

ContraFect:

Session 411: AAR08 – New Antimicrobial Agents and New Research Technologies: New Agents or Combinations that Inhibit Mycobacteria
Time: 12:45 p.m. – 2:45 p.m. ET
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Spero Therapeutics:

Session 412: AAR08 – New Antimicrobial Agents and New Research Technologies: New Cephalosporins, Penems, and Carbapenems
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Iterum Therapeutics:

Spero Therapeutics:

Session 417: CIV01 – Clinical Studies of Adult Infectious Diseases: Respiratory Tract Infections
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Nabriva Therapeutics:

Session 420 – CIV02 – Infection Prevention and Control: Drug-Resistant Pathogens in Hospitals
Time: 12:45 p.m. – 2:45 p.m.
Location: Exhibit and Poster Hall, Building B, Halls B2-B5

Melinta Therapeutics:

Session 495: The Clinical Microbiology Laboratory of the Future (Organized in Cooperation with ESCMID and AMMI Canada)
Time: 3:00 p.m. – 5:30 p.m.
Location: A315-A316

T2 Biosystems:
4:15 p.m. – 4:30 p.m.